The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2021 | IMW 2021: MRD highlights
Daniel Auclair
• 11 Sep 2021
Daniel Auclair, PhD, of the Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, gives an overview of the key updates on the use of measurable residual disease (MRD) in myeloma, as presented at the IMW 2021 meeting, and discusses updates and sessions which will take place at the upcoming MMRF MRD Meeting on October 13th. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.
